MedSci Health Appoints Fan Jie, Former Xi'an Janssen Executive, as CEO to Accelerate Digital Healthcare Innovation

On March 1, MedSci officially announced the appointment of Mr. Fan Jie as Chief Executive Officer, formally joining MedSci to fully participate in strategic planning and business management.

Fan Jie | CEO of MedSci

Mr. Fan Jie has an extensive 27-year career in the pharmaceutical industry. Before joining MedSci, he served as the General Manager of Actelion Pharmaceuticals Trading Shanghai Co., Ltd. and as a senior executive at Xian Janssen Pharmaceutical Ltd. Earlier in his career, he also worked for renowned multinational pharmaceutical companies such as Schering-Plough. With professional industry insights, a keen ability to seize business opportunities, advanced management methods, an unwavering determination to surpass himself and accomplish missions, and a win-win cooperation philosophy with clients and teams, Mr. Fan Jie achieved remarkable success by consistently exceeding targets for several consecutive years.

Mr. Fan Jie said, "I am honored to join MedSci. In the future, I will work with MedSci to create meaningful, nation- and people-benefiting undertakings." Mr. Fan believes that the government is accelerating the introduction of new technologies and medicines into China to solve the problem of Chinese patients having "difficulty and high cost in accessing medical treatment." In this process, two types of pharmaceutical enterprises can ride the wave of development and stand at the forefront. One type creates value, and the other delivers value. MedSci has profound scientific research capabilities, digital clinical research capabilities, digital academic communication abilities, and a loyal customer base of doctors accumulated over more than 20 years, which is helping its clients, especially industrial pharmaceutical companies, achieve value delivery.

Mr. Fan Jie also presented his prospects for the company. In the future, MedSci will apply big data and artificial intelligence technology to connect doctors, patients, and pharmaceutical and medical device enterprises, acting as a good assistant to hospitals and doctors. It will strengthen and promote cooperation with secondary and tertiary hospitals in key cities as well as important hospitals in second- and third-tier cities in China, gaining more attention from the physician community. MedSci will deeply explore the needs of B-end enterprises—educating medical experts to enable more patients to access high cost-effective drugs, educating medical insurance experts to facilitate the implementation of drug coverage under medical insurance, educating hospital administrators to solve the issue of drug procurement, and educating patients to ensure effective and safe medication use—thus comprehensively addressing customer challenges. The company will focus on digital RWE (Real-World Evidence) studies, providing strong data and evidence support for enterprises. With its robust medical expertise, MedSci will precisely reach target doctors and patients, efficiently benefiting the public.

MedSci Chairman Dr. Zhang Fabao welcomed Fan Jie to the team, stating: "We are very pleased to have a senior manager like Fan Jie join the MedSci family, leading MedSci to reach new heights in future development. We also hope more industry elites will join MedSci to create a digital healthcare future together."

About MedSci

MedSci is a comprehensive internet platform for doctors, utilizing big data and artificial intelligence technology to connect doctors, patients, and pharmaceutical device companies. It provides precise digital medical communication solutions, empowers the healthcare ecosystem, improves medical quality, and creates a better healthy life. The main products include digital medical communication and digital clinical research, covering areas such as clinical research, doctor career growth, multi-channel academic communication, marketing consulting services, smart healthcare, and internet hospitals. It offers overall solutions for clinical research, reducing costs and improving quality through digital technology; provides professional medical content and precise, integrated communication solutions digitally, delivering the latest disease knowledge and pharmaceutical device product information accurately to target doctors and patients, quickly benefiting more target patients.